Sequana Medical NV
XBRU:SEQUA

Watchlist Manager
Sequana Medical NV Logo
Sequana Medical NV
XBRU:SEQUA
Watchlist
Price: 2.76 EUR 33.33% Market Closed
Market Cap: 122.6m EUR
Have any thoughts about
Sequana Medical NV?
Write Note

Sequana Medical NV
Investor Relations

Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Ian Crosbie
CEO & Executive Director
No Bio Available
Ms. Kirsten Van Bockstaele
Chief Financial Officer
No Bio Available
Ms. Lies Vanneste
Director of Investor Relations
No Bio Available
Mr. Martijn Blom
Chief Commercial Officer
No Bio Available
Dr. Oliver Godje M.D., Ph.D.
Chief Medical Officer
No Bio Available

Contacts

Address
OOST-VLAANDEREN
Ghent
Kortrijksesteenweg 1112, Sint-Denijs-Westrem
Contacts